naion and semaglutide Breaking Med Does semaglutide increase the risk

It is well known that increased glutamate levels are associated with increased neuronal activity, leading to glutamate-induced excitotoxicity via reactive oxygen species (ROS) production [65, 66]

Further reading FcRn blockade in CIDP (ADHERE trial) The Lancet Neurology 2024 #PatientEducation #CIDP #Neuromuscular #EvidenceBasedMedicine Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial thelancet.com To view or add a comment, sign in Platelet Hyperreactivity: A Novel Peripheral Biomarker for Preclinical Alzheimers

Following the recommended dose schedule gives your body time to adapt and may improve tolerance

stopping GLP-1 injectables Most people don't realize that synthetic GLP-1 hormones reduce your natural GLP-1 production to zero -- a normal response when you're getting hormones exogenously (your body goes "on holiday" and stops producing)

According to a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society, a daily protein intake of 1.21.6 g/kg adjusted body weight, should be considered in individuals initiating GLP-1RA therapy, particularly when caloric restriction is prescribed